A Performance-Based Adaptation Index for Automated Insulin Delivery Systems

Abstract

Background:

Automated insulin delivery (AID) algorithms can benefit from tuning of their aggressiveness to meet individual needs, as insulin requirements vary among and within users. We introduce the Performance-Based Adaptation Index (PAI), a tool designed to enable automatic adjustment of an AID system aggressiveness based on continuous glucose monitoring (CGM) metrics.

Methods:

PAI integrates two CGM-based metrics—one for hypoglycemia and another for hyperglycemia exposure—over a previous time window into a single index ( $α_{θ}$ ). We propose two methods to compute $α_{θ}$ : one based on time in range (TIR, 70-180 mg/dL), and the other on glycemic risk indices. Using $α_{θ}$ , we developed a multiplicative strategy to adjust the AID system’s aggressiveness, accounting for situations where $α_{θ}$ cannot be reliably calculated. The feasibility of this method was assessed in-silico using the UVA/Padova Type 1 Diabetes Simulator and our full closed-loop algorithm (UVA-model predictive control (MPC)) across five scenarios: optimal tuning (baseline), conservative and aggressive tunings, and temporary and permanent changes in insulin needs. Glycemic outcomes were evaluated from the simulated glucose traces.

Results:

Negligible performance variations were observed in the baseline scenario. For the conservative scenario, adjusting $α_{θ}$ improved TIR (35.1% vs 71.8%) and increased total daily insulin (32.1 U vs 41.2 U). Conversely, for the aggressive scenario, it reduced hypoglycemia exposure (TBR: 2.6% vs 1.4%) and overall insulin usage (45.6 U vs 43.0 U).

Conclusion:

In-silico results demonstrated the safety and efficacy of using PAI to automatically tune the UVA-MPC controller, achieving TIR values above 70% under fully closed-loop conditions and across various physiological states. Clinical validation of these results is warranted.

Keywords

automated insulin delivery glucose control artificial pancreas insulin therapy adaptation type 1 diabetes fully automated closed loop

Get full access to this article

View all access options for this article.

References

Sherr

Heinemann

Fleming

, et al. Automated insulin delivery: benefits, challenges, and recommendations. A consensus report of the joint diabetes technology working group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetes Care. 2022;45(12):3058-3074. doi:10.2337/DCI22-0018.

Almurashi

Rodriguez

Garg

. A multidisciplinary reviews journal emerging diabetes technologies: continuous glucose monitors/artificial pancreases. J Indian Inst Sci. 2023;103:205-230. doi:10.1007/s41745-022-00348-3.

Brown

Forlenza

Bode

, et al. Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes. Diabetes Care. 2021;44(7):1630-1640. doi:10.2337/DC21-0172.

Karol

O’Malley

Fallurin

Levy

. Automated insulin delivery systems as a treatment for type 2 diabetes mellitus: a review. Endocr Pract. 2023;29(3):214-220. doi:10.1016/j.eprac.2022.10.001.

Turksoy

Cinar

. Adaptive control of artificial pancreas systems—a review. J Healthc Eng. 2014;5(1):1-22.

Toffanin

Visentin

Messori

Palma

Magni

Cobelli

. Toward a run-to-run adaptive artificial pancreas: in silico results. IEEE Trans Biomed Eng. 2018;65(3):479-488. doi:10.1109/TBME.2017.2652062.

Resalat

Hilts

Youssef

Tyler

Castle

Jacobs

. Adaptive control of an artificial pancreas using model identification, adaptive postprandial insulin delivery, and heart rate and accelerometry as control inputs. J Diabetes Sci Technol. 2019;13(6):1044-1053. doi:10.1177/1932296819881467.

Eren-Oruklu

Cinar

Quinn

Smith

. Adaptive control strategy for regulation of blood glucose levels in patients with type 1 diabetes. J Process Control. 2009;19(8):1333-1346. doi:10.1016/j.jprocont.2009.04.004.

Hajizadeh

Rashid

Samadi

, et al. Adaptive personalized multivariable artificial pancreas using plasma insulin estimates. J Process Control. 2019;80:26-40. doi:10.1016/j.jprocont.2019.05.003.

10.

Hajizadeh

Rashid

Sevil

, et al. Adaptive model predictive control for nonlinearity in biomedical applications. IFAC-PapersOnLine. 2018;51(20):368-373. doi:10.1016/j.ifacol.2018.11.061.

11.

Villa-Tamayo

Rivadeneira

. Adaptive impulsive offset-free MPC to handle parameter variations for type 1 diabetes treatment. Ind Eng Chem Res. 2020;59(13):5865-5876. doi:10.1021/acs.iecr.9b05979.

12.

Shi

Dassau

Doyle

. Adaptive zone model predictive control of artificial pancreas based on glucose- and velocity-dependent control penalties. IEEE Trans Biomed Eng. 2019;66(4):1045-1054. doi:10.1109/TBME.2018.2866392.

13.

Berget

Sherr

DeSalvo

, et al. Clinical implementation of the Omnipod 5 automated insulin delivery system: key considerations for training and onboarding people with diabetes. Clin Diabetes. 2022;40(2):168-184. doi:10.2337/CD21-0083.

14.

Kovatchev

. Glycemic variability: risk factors, assessment, and control. J Diabetes Sci Technol. 2019;13(4):627-635. doi:10.1177/1932296819826111.

15.

Garcia-Tirado

Corbett

Colmegna

Breton

. Advanced hybrid artificial pancreas system improves on unannounced meal response—In silico comparison to currently available system. Comput Methods Programs Biomed. 2021;211:106401. doi:10.1016/J.CMPB.2021.106401.

16.

Garcia-Tirado

Diaz

Esquivel-Zuniga

, et al. Advanced closed-loop control system improves postprandial glycemic control compared with a hybrid closed-loop system following unannounced meal. Diabetes Care. 2021;44(10):2379-2387. doi:10.2337/DC21-0932.

17.

Corbett

Garcia-Tirado

Colmegna

Diaz Castaneda

Breton

. Using an online disturbance rejection and anticipation system to reduce hyperglycemia in a fully closed-loop artificial pancreas system. J Diabetes Sci Technol. 2022;16(1):52-60. doi:10.1177/19322968211059159.

18.

Colmegna

Diaz

Garcia-Tirado

Breton

. Enabling anticipatory response in multi-stage MPC formulation for fully automated artificial pancreas system. Paper presented at the Proceedings of the 2022 IEEE 61st Conference on Decision and Control; December 2022; Cancun, Mexico. doi:10.1109/CDC51059.2022.9993157.

19.

Breton

Keith-Hynes

, et al. Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp. Diabetes Care. 2014;37(8):2310-2316. doi:10.2337/dc14-0147.

20.

Moscoso-Vásquez

Garcia-Tirado

Colmegna

Breton

. Reshaping model predictive control penalties for an automated insulin delivery system in type 1 diabetes. IFAC-PapersOnLine. 2023;56(2):9660-9665. doi:10.1016/J.IFACOL.2023.10.274.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.19 MB